✦ LIBER ✦

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients

✍ Scribed by Berg, Thomas; Zoulim, Fabien; Moeller, Bernd; Trinh, Huy; Marcellin, Patrick; Chan, Sing; Kitrinos, Kathryn M.; Dinh, Phillip; Flaherty, John F.; McHutchison, John G.; Manns, Michael

Book ID: 122207776
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 757 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2013.11.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

929 EVALUATION OF SAFETY AND TOLERABILIT

929 EVALUATION OF SAFETY AND TOLERABILITY OF TENOFOVIR DF (TDF) LONG TERM MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE EXPERIENCED PATIENTS WITH HBV MONOINFECTION

✍ F. van Bömmel; R. deMan; P. Ferenci; J.P. Bronowiki; H. Wedemeyer; A. Erhardt; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

530 HIGH EFFICACY AND SAFETY OF TENOFOVI

530 HIGH EFFICACY AND SAFETY OF TENOFOVIR DF IN 441 NAIVE AND NUC-EXPERIENCED CHRONIC HEPATITIS B PATIENTS: A REAL LIFE MULTICENTER PROSPECTIVE COHORT STUDY

✍ P. Marcellin; F. Zoulim; X. Causse; C. Hézode; D. Larrey; G. Pageaux; B. Roche; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Efficacy and tolerance of a combination

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study

✍ Si-Nafa Si-Ahmed; Pierre Pradat; Roeland Zoutendijk; Maria Buti; Vincent Mallet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 521 KB

P1058 LONG-TERM EFFICACY OF TENOFOVIR IN

P1058 LONG-TERM EFFICACY OF TENOFOVIR IN PREVIOUSLY TREATED AND NAIVE PATIENTS. RESULTS FROM THE SPANISH CHRONIC HEPATITIS B REGISTRY (CIBERHEP)

✍ Tabernero, D.; Sánchez-Tapias, J.M.; Calleja, J.L.; Moreira, V.; Manzano, M.L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Long-term efficacy and emergence of mult

Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine

✍ Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, T 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 362 KB

46 Three year study of adefovir dipivoxi

46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

✍ S. Hadziyannis; N. Tassopoulos; T.T. Chang; J. Heathcote; G. Kitis; M. Rizzetto; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB